BERGEN, Norway, Oct. 27, 2021 /PRNewswire/ -- Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumor membrane immunotherapy, CyPep-1, announces the appointment of Bo Jesper Hansen MD, PhD as strategic advisor to the Board....
from PR Newswire: https://ift.tt/3buqpkV
No comments:
Post a Comment